# Study of DA+LDD in the Treatment of Femoropopliteal Occlusive Disease

> **NCT03380650** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Peripheral Artery Disease
- Endovascular Treatment

## Interventions

- **DEVICE:** directional atherectomy and locol drug delivery
- **DEVICE:** drug-coated balloon dilation

## Key facts

- **NCT ID:** NCT03380650
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03380650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03380650, "Study of DA+LDD in the Treatment of Femoropopliteal Occlusive Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03380650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*